Abstract
To counter the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), some have proposed accelerating SARS-CoV-2 vaccine development through controlled human infection (or 'challenge') trials. These trials would involve the deliberate exposure of relatively few young, healthy volunteers to SARS-CoV-2. We defend this proposal against the charge that there is still too much uncertainty surrounding the risks of COVID-19 to responsibly run such a trial.
Original language | English (US) |
---|---|
Pages (from-to) | 808-812 |
Number of pages | 5 |
Journal | Journal of Medical Ethics |
Volume | 46 |
Issue number | 12 |
DOIs | |
State | Published - Dec 1 2020 |
All Science Journal Classification (ASJC) codes
- Health(social science)
- Arts and Humanities (miscellaneous)
- Health Policy
- Issues, ethics and legal aspects
Keywords
- clinical trials
- ethics
- philosophical ethics
- research ethics